title: The use of alefacept in the treatment of psoriasis.
authors.affiliation: Mediprobe Research Inc., London, Ontario, Canada.
authors.forename: Richard
authors.initials: R
authors.lastname: Langley
authors.forename: Aditya K
authors.initials: AK
authors.lastname: Gupta
authors.forename: Yves
authors.initials: Y
authors.lastname: Poulin
authors.forename: Lyn
authors.initials: L
authors.lastname: Guenther
authors.forename: Kirk
authors.initials: K
authors.lastname: Barber
authors.forename: Wayne
authors.initials: W
authors.lastname: Gulliver
authors.forename: Charles
authors.initials: C
authors.lastname: Lynde
mesh_terms: D000077944:Alefacept; D001688:Biological Products / Q000627:therapeutic use; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D011565:Psoriasis / Q000188:drug therapy*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000502:physiology; D016896:Treatment Outcome
chemical_list: D001688:Biological Products; D011993:Recombinant Fusion Proteins; D000077944:Alefacept